top of page

Shaping the future of personalized healthcare with an accurate & affordable 
home diagnostic device

arrow
E3D84533-AF3F-40CC-BD54-74B016C8E4AE.png

Compact and affordable ‘lab at home’ sample analyser 

WhatsApp Image 2024-04-07 at 21.10.40.jpeg

Photonic chips for multianalyte testing (Disposable, low-cost, multi-omics)

Gemini_Generated_Image_dnk8bidnk8bidnk88.jpg

Timely and actionable insights for disease management

Tech

Luma’s technology is based on Photonic Integrated Circuits (PICs) — the light-based equivalent of electronic integrated circuits. Silicon PICs are proven to have significant biosensing and diagnostic capabilities. This has been demonstrated by commercial companies and thousands of published scientific papers. However, commercialization of these solutions for home use has been limited due to the high associated costs. 

Luma has pioneered and developed the world’s first, fully operational polymeric PICs, which exhibit optical properties comparable to their Silicon counterparts. The significant cost reduction of polymeric PICs, while maintaining comparable optical properties, paves the way towards a sensitive, rapid, multi-omics, low-cost solution for the home testing market.

Opportunities

Exciting opportunities
for Luma’s platform ——————————————

auto.jpg

Autoimmune Diseases

- Autoimmune diseases affect about one in ten individuals (!) - $15B by 2033. 
- Unpredictable disease flares cause significant clinical & financial burden.
- The Luma solution would diagnose exacerbations early, allowing patient-      tailored preventive strategies (e.g.,Lupus, IBD, MS).

PLACEHOLDER_image8.jpg

Clinical Drug Development

- Clinical trials is a huge market undergoing decentralization.
- More than 6000 ongoing clinical trials involving Immunology alone.
- The Luma solution can be leveraged for improved drug development of immune-related drugs.

STD.jpg

Sexually Transmitted Diseases

- More than 20 million estimated new cases in the United States each year.

- Expensive ($150) mail-in tests are the only choice for home testing with waiting time of several days for results.

- The Luma solution could capture a significant share of this huge market (99B USD in 2027).

team

We are Luma

Luma Biophotonics has a multidisciplinary team of experts in physics, engineering, biotechnology, pharmaceuticals, business, and more

DSC_9364.jpg

Ofer Bar-On

Co-founder and CEO

10 years of experience in polymer based photonic integrated circuits, both in theory and manufacturing. Ph.D. in optics and nanotechnology (Tel-Aviv University) 

DSC_9689.jpg

Omer Kotlicki
Co-founder and CTO

More than 20 years of experience in optics, electronics and IT, both industry and academy. Ph.D. in electrical engineering (Tel-Aviv University)

PLACEHOLDER_image15.jpg

Dorit Sokolov

Chief Business Officer

Multi-disciplinary early-stage Biotech & HealthTech investor and company builder with significant passion for innovation, venture creation, business development and bringing novel medical products to market.

1516241741552.jpg

Giora Volpert

VP R&D

Bio convergence expert; Ph.D in Biochemistry (The Weizmann Institute of Science); Years of experience in commercial development of biosensors and multidisciplinary medical devices (Vensice Medical, Ador Diagnostics).

DSC_9787.jpg

Daniel Woolman

Supply Chain Management

Experienced co-founder of two engineering and manufacturing companies. 

image12.jpg

Lina Kanyavskaya, Research Assistant in Biochemistry

M.Sc in Biotechnology. Experienced researcher in the fields of molecular biology and biochemistry.

image11.jpg

Michael Chasnitsky
Head of Integrated Photonics

Ph.D. From the Hebrew University. An experienced physicist with background in nanotechnology, wave propagation, and plasmonics.

Scientific Advisory Board

PLACEHOLDER_image17.jpg

Michal Stein

M.D. (Hebrew University), Head of Pediatric Infectious Disease Unit, Sheba Hospital and chair of the Israeli Society of Pediatric Infectious Diseases.

PLACEHOLDER_image19.gif

Aviram Hochstadt 

M.D. (Hebrew University), M.P.H (Tel-Aviv University) Senior physician in cardiology and internal medicine, EP Fellow at NYU Langone Health.

PLACEHOLDER_image18.jpg

Prof. Jacob Scheuer

Senior professor at the department of electrical engineering at Tel Aviv University and Author of more than 150 scientific papers and 10 patents in the field of optics.

PLACEHOLDER_image16.jpg

Ari Tadmor

Former CEO of ADOR Diagnostics, a molecular diagnostics company. PhD in biology (The Weizmann Institute of Science). An experienced executive in the diagnostics field. 

contact

Luma is always searching for talented people.

We invite you to join our team!

Thanks for reaching out!

bottom of page